Cited by 44Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer’s disease pathologies

Open access
Chen, Guiqin, Kang, Seong Su, Wang, Zhihao, Ahn, Eun Hee, Xia, Yiyuan, Liu, Xia, Sandoval, Ivette M., Manfredsson, Fredric P. +2 more·2021·Science Advances

Abstract

Netrin-1 reduction activates AEP that cleaves UNC5C receptor, contributing to AD pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.abe4499

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • δ-Secretase precuts APP, facilitating β-secretase 1 access, and simultaneously cleaves TrkB, tau, and UNC5C, amplifying both Aβ production and tau pathology.

    “For example, δ-Secretase precuts APP, facilitating β-secretase 1 access, and simultaneously cleaves proteins such as tropomyosin receptor kinase B (TrkB), tau, and netrin receptor (UNC5C), amplifying both Aβ production and tau pathology [32].”

    From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [32]

    The Introduction and Results report that δ-secretase cleaves APP, tau, and UNC5C, with increased Aβ production and tau-related pathology. The Results identify APP cleavage at N585, but do not say that this gives β-secretase 1 access. The Discussion says cleaved tau binds TrkB and inhibits its signaling; it does not say δ-secretase cleaves TrkB. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. [1]D. M. Holtzman, J. C. Morris, A. M. Goate, Alzheimer’s disease: The challenge of the second century. Sci. Transl. Med. 3, 77sr71 (2011). PMC3130546 21471435
  2. [2]S. W. Moore, M. Tessier-Lavigne, T. E. Kennedy, Netrins and their receptors. Adv. Exp. Med. Biol. 621, 17– 31 (2007). 18269208
  3. [3]K. Hong, L. Hinck, M. Nishiyama, M. M. Poo, M. Tessier-Lavigne, E. Stein, A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97, 927– 941 (1999). 10399920
  4. [4]D. Bradford, S. J. Cole, H. M. Cooper, Netrin-1: Diversity in development. Int. J. Biochem. Cell Biol. 41, 487– 493 (2009). 18455953
  5. [5]M. Shabani, M. Haghani, P. E. Tazangi, M. Bayat, S. M. Shid Moosavi, H. Ranjbar, Netrin-1 improves the amyloid-β-mediated suppression of memory and synaptic plasticity. Brain Res. Bull. 131, 107– 116 (2017). 28389207
  6. [6]E. Zamani, M. Parviz, M. Roghani, P. Mohseni-Moghaddam, Key mechanisms underlying netrin-1 prevention of impaired spatial and object memory in Aβ1-42 CA1-injected rats. Clin. Exp. Pharmacol. Physiol. 46, 86– 93 (2019). 30066400
  7. [7]L. Sun, T. Ju, T. Wang, L. Zhang, F. Ding, Y. Zhang, R. An, Y. Sun, Y. Li, Y. Lu, X. Zhang, L. Chi, Decreased netrin-1 and correlated Th17/Tregs balance disorder in Aβ1–42 induced Alzheimer’s disease model rats. Front. Aging Neurosci. 11, 124 (2019). 31191297 PMC6548067
  8. [8]F. C. Lourenço, V. Galvan, J. Fombonne, V. Corset, F. Llambi, U. Müller, D. E. Bredesen, P. Mehlen, Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β production. Cell Death Differ. 16, 655– 663 (2009). 19148186 PMC2757418
  9. [9]N. Rama, D. Goldschneider, V. Corset, J. Lambert, L. Pays, P. Mehlen, Amyloid precursor protein regulates netrin-1-mediated commissural axon outgrowth. J. Biol. Chem. 287, 30014– 30023 (2012). 22782894 PMC3436182
  10. [10]P. G. Ridge, K. B. Hoyt, K. Boehme, S. Mukherjee, P. K. Crane, J. L. Haines, R. Mayeux, L. A. Farrer, M. A. Pericak-Vance, G. D. Schellenberg, J. S. K. Kauwe; Alzheimer’s Disease Genetics Consortium (ADGC), Assessment of the genetic variance of late-onset Alzheimer’s disease. Neurobiol. Aging 41, 200.e13– 200.e20 (2016). PMC4948179 27036079
  11. [11]M. K. Wetzel-Smith, J. Hunkapiller, T. R. Bhangale, K. Srinivasan, J. A. Maloney, J. K. Atwal, S. M. Sa, M. B. Yaylaoglu, O. Foreman, W. Ortmann, N. Rathore, D. V. Hansen, M. Tessier-Lavigne; Alzheimer’s Disease Genetics Consortium, R. Mayeux, M. Pericak-Vance, J. Haines, L. A. Farrer, G. D. Schellenberg, A. Goate, T. W. Behrens, C. Cruchaga, R. J. Watts, R. R. Graham, A rare mutation in UNC5C predisposes to late-onset Alzheimer’s disease and increases neuronal cell death. Nat. Med. 20, 1452– 1457 (2014). 25419706 PMC4301587
  12. [12]Y. Hashimoto, Y. Toyama, S. Kusakari, M. Nawa, M. Matsuoka, An Alzheimer disease-linked rare mutation potentiates netrin receptor uncoordinated-5C-induced signaling that merges with amyloid β precursor protein signaling. J. Biol. Chem. 291, 12282– 12293 (2016). 27068745 PMC4933276
  13. [13]J.-H. Sun, H.-F. Wang, X.-C. Zhu, W.-J. Yu, C.-C. Tan, T. Jiang, M.-S. Tan, L. Tan, J.-T. Yu; Alzheimer’s Disease Neuroimaging Initiative, The impact of UNC5C genetic variations on neuroimaging in Alzheimer’s disease. Mol. Neurobiol. 53, 6759– 6767 (2016). 26660111
  14. [14]H.-S. Yang, C. C. White, L. B. Chibnik, H.-U. Klein, J. A. Schneider, D. A. Bennett, P. L. De Jager, UNC5C variants are associated with cerebral amyloid angiopathy. Neurol. Genet. 3, e176 (2017). 28761931 PMC5515600
  15. [15]D. N. Li, S. P. Matthews, A. N. Antoniou, D. Mazzeo, C. Watts, Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278, 38980– 38990 (2003). 12860980
  16. [16]L. Zhao, T. Hua, C. Crowley, H. Ru, X. Ni, N. Shaw, L. Jiao, W. Ding, L. Qu, L.-W. Hung, W. Huang, L. Liu, K. Ye, S. Ouyang, G. Cheng, Z.-J. Liu, Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell Res. 24, 344– 358 (2014). 24407422 PMC3945893
  17. [17]Z. Liu, S.-W. Jang, X. Liu, D. Cheng, J. Peng, M. Yepes, X.-j. Li, S. Matthews, C. Watts, M. Asano, I. Hara-Nishimura, H. R. Luo, K. Ye, Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol. Cell 29, 665– 678 (2008). 18374643 PMC2819101
  18. [18]G. Basurto-Islas, J.-H. Gu, Y. C. Tung, F. Liu, K. Iqbal, Mechanism of tau hyperphosphorylation involving lysosomal enzyme asparagine endopeptidase in a mouse model of brain ischemia. J. Alzheimers Dis. 63, 821– 833 (2018). 29689717
  19. [19]Z. Zhang, M. Song, X. Liu, S. S. Kang, I.-S. Kwon, D. M. Duong, N. T. Seyfried, W. T. Hu, Z. Liu, J.-Z. Wang, L. Cheng, Y. E. Sun, S. P. Yu, A. I. Levey, K. Ye, Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat. Med. 20, 1254– 1262 (2014). 25326800 PMC4224595
  20. [20]Z. Zhang, M. Song, X. Liu, S. S. Kang, D. M. Duong, N. T. Seyfried, X. Cao, L. Cheng, Y. E. Sun, S. P. Yu, J. Jia, A. I. Levey, K. Ye, Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat. Commun. 6, 8762 (2015). 26549211 PMC4659940
  21. [21]A. Leuzy, C. Cicognola, K. Chiotis, L. Saint-Aubert, L. Lemoine, N. Andreasen, H. Zetterberg, K. Ye, K. Blennow, K. Höglund, A. Nordberg, Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging 46, 1152– 1163 (2019). 30610252 PMC6451715
  22. [22]A. Paradisi, C. Maisse, M.-M. Coissieux, N. Gadot, F. Lépinasse, C. Delloye-Bourgeois, J.-G. Delcros, M. Svrcek, C. Neufert, J.-F. Fléjou, J.-Y. Scoazec, P. Mehlen, Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc. Natl. Acad. Sci. U.S.A. 106, 17146– 17151 (2009). 19721007 PMC2761333
  23. [23]P. Mehlen, C. Guenebeaud, Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr. Opin. Oncol. 22, 46– 54 (2010). 19934758
  24. [24]P. Mehlen, C. Furne, Netrin-1: When a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell. Mol. Life Sci. 62, 2599– 2616 (2005). 16158190 PMC11139161
  25. [25]P. Mehlen, S. Rabizadeh, S. J. Snipas, N. Assa-Munt, G. S. Salvesen, D. E. Bredesen, The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395, 801– 804 (1998). 9796814
  26. [26]F. Llambi, F. Causeret, E. Bloch-Gallego, P. Mehlen, Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 20, 2715– 2722 (2001). 11387206 PMC125255
  27. [27]E. Dall, H. Brandstetter, Structure and function of legumain in health and disease. Biochimie 122, 126– 150 (2016). 26403494
  28. [28]O. del Pozo, E. Lam, Caspases and programmed cell death in the hypersensitive response of plants to pathogens. Curr. Biol. 8, R896– R897 (1998). 9843696
  29. [29]A. J. De Jong, F. A. Hoeberichts, E. T. Yakimova, E. Maximova, E. J. Woltering, Chemical-induced apoptotic cell death in tomato cells: Involvement of caspase-like proteases. Planta 211, 656– 662 (2000). 11089678
  30. [30]J. M. Chen, P. M. Dando, N. D. Rawlings, M. A. Brown, N. E. Young, R. A. Stevens, E. Hewitt, C. Watts, A. J. Barrett, Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272, 8090– 8098 (1997). 9065484
  31. [31]Z.-H. Wang, P. Liu, X. Liu, F. P. Manfredsson, I. M. Sandoval, S. P. Yu, J.-Z. Wang, K. Ye, Delta-secretase phosphorylation by srpk2 enhances its enzymatic activity, provoking pathogenesis in Alzheimer’s disease. Mol. Cell 67, 812– 825.e5 (2017). 28826672 PMC5753427
  32. [32]Z.-H. Wang, W. Wu, S. S. Kang, X. Liu, Z. Wu, J. Peng, S. P. Yu, F. P. Manfredsson, I. M. Sandoval, X. Liu, J.-Z. Wang, K. Ye, BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3, e99007 (2018). PMC6141178 30135302
  33. [33]Z.-H. Wang, J. Xiang, X. Liu, S. P. Yu, F. P. Manfredsson, I. M. Sandoval, S. Wu, J.-Z. Wang, K. Ye, Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer’s disease. Cell Rep. 28, 655– 669.e5 (2019). 31315045 PMC6684282
  34. [35]D. Kim, S. L. Ackerman, The UNC5C netrin receptor regulates dorsal guidance of mouse hindbrain axons. J. Neurosci. 31, 2167– 2179 (2011). 21307253 PMC3073835
  35. [36]Q. Li, B.-L. Wang, F.-R. Sun, J.-Q. Li, X.-P. Cao, L. Tan, The role of UNC5C in Alzheimer’s disease. Ann. Transl. Med. 6, 178 (2018). 29951500 PMC5994511
  36. [37]K. Thiébault, L. Mazelin, L. Pays, F. Llambi, M.-O. Joly, J.-Y. Scoazec, J.-C. Saurin, G. Romeo, P. Mehlen, The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc. Natl. Acad. Sci. U.S.A. 100, 4173– 4178 (2003). 12655055 PMC153067
  37. [38]A. Bernet, L. Mazelin, M.-M. Coissieux, N. Gadot, S. L. Ackerman, J.-Y. Scoazec, P. Mehlen, Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133, 1840– 1848 (2007). 17967459 PMC2211510
  38. [39]X. Tang, S.-W. Jang, M. Okada, C.-B. Chan, Y. Feng, Y. Liu, S.-W. Luo, Y. Hong, N. Rama, W.-C. Xiong, P. Mehlen, K. Ye, Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B. Nat. Cell Biol. 10, 698– 706 (2008). 18469807 PMC2839190
  39. [42]C. Delloye-Bourgeois, J. Fitamant, A. Paradisi, D. Cappellen, S. Douc-Rasy, M.-A. Raquin, D. Stupack, A. Nakagawara, R. Rousseau, V. Combaret, A. Puisieux, D. Valteau-Couanet, J. Bénard, A. Bernet, P. Mehlen, Netrin-1 acts as a survival factor for aggressive neuroblastoma. J. Exp. Med. 206, 833– 847 (2009). 19349462 PMC2715117
  40. [43]Z. Zhang, S. S. Kang, X. Liu, E. H. Ahn, Z. Zhang, L. He, P. M. Iuvone, D. M. Duong, N. T. Seyfried, M. J. Benskey, F. P. Manfredsson, L. Jin, Y. E. Sun, J.-Z. Wang, K. Ye, Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson’s disease. Nat. Struct. Mol. Biol. 24, 632– 642 (2017). 28671665 PMC5871868

Cited by

Sorted by citations

Authors
Chen, G., Kang, S. S., Wang, Z., Ahn, E. H., Xia, Y., Liu, X., Sandoval, I. M., Manfredsson, F. P., Zhang, Z., & Ye, K.
Affiliations
  • Emory University (US)
  • Barrow Neurological Institute (US)
  • Renmin Hospital of Wuhan University (CN)
Corresponding author
  • Zhang, Zhaohui
  • Ye, Keqiang
Venue
Science Advances
Published
2021-04-16
Volume
7
Issue
16
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3153292507
Cited by
44
References
3
Citations by year
2026: 1 · 2025: 13 · 2024: 9 · 2023: 12 · 2022: 5 · 2021: 4
FWCI
4.71
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (AG051538)
  • National Institute of Neurological Disorders and Stroke (P30NS055077)
  • Alzheimer’s Disease Research Center, Emory University (P30 AG066511)
  • National Natural Science Foundation of China (81671051)
  • National Institutes of Health under Award Number (UL1TR002378)
  • National Institute of Health RF1 (AG051538)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
netrin-1, UNC5C, Alzheimer's disease, neurodegeneration, neuronal apoptosis, caspase-3 activation, APP/PS1 mice, learning and memory impairment, axon guidance receptors
MeSH terms
Netrin Receptors, Netrin-1, Alzheimer Disease, Animals, Cell Death, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review